| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 04/19/2006 | EP0762901B1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING |
| 04/19/2006 | CN1761683A Cancerous disease modifying antibodies |
| 04/19/2006 | CN1761489A Conjugates for medical imaging comprising carrier, targeting moiety and a contrast agent |
| 04/19/2006 | CN1761488A Vitamin receptor binding drug delivery conjugates |
| 04/19/2006 | CN1761482A Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 04/19/2006 | CN1761477A Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
| 04/19/2006 | CN1251767C Kit for radiolabeling proteins with yttrium-90 |
| 04/18/2006 | US7030110 Cyclic oxyguanidine pyrazinones as protease inhibitors |
| 04/18/2006 | US7030109 1,2,3,4,5,6-Hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position |
| 04/18/2006 | US7029653 Method of the administration of drugs having binding affinity with plasma protein and preparation to be used in the method |
| 04/18/2006 | US7029652 Administering dose of antiangiogenic cyclo-arginine-glycine-aspartic acid- containing pentapeptide (cRGD pentapeptide), radioimmunotherapeutic agent (RIT), and one additional dose of cRGD pentapeptide |
| 04/18/2006 | US7029431 Directional-ionizing energy emitting implant |
| 04/13/2006 | WO2006039418A2 Human monoclonal antibodies to fc gamma receptor ii (cd32) |
| 04/13/2006 | WO2006038185A2 Use of the staudinger ligation in imaging and therapy end kits for imaging and therapy |
| 04/13/2006 | WO2006038184A2 Compounds, kits and methods for use in medical imaging |
| 04/13/2006 | WO2006037988A2 Novel technetium and rhenium complexes, ligands used in their preparation and their use as radiopharmaceuticals |
| 04/13/2006 | WO2006037882A1 Use of vcam-1 ligands for detecting and/or treating cardiovascular diseases |
| 04/13/2006 | WO2006014381A9 Use of thioflavin radiolabeled derivatives in amyloid imaging gor assessing anti-amyloid therapies |
| 04/13/2006 | WO2005116255A3 Aptamer-toxin molecules and method for using same |
| 04/13/2006 | WO2005056058A3 Radiosensitizer conjugate to improve the efficacy of radiolabeled drugs |
| 04/13/2006 | US20060079516 Highly concentrated stable meloxicam solutions |
| 04/13/2006 | US20060078503 1,4,7,10-Tetraazacyclododecane butyltriols, processes for their production and pharmaceutical agents containing them |
| 04/13/2006 | US20060078496 Method of drug delivery to interstitial regions of the myocardium |
| 04/13/2006 | US20060078495 Stereoisomers of fatty acid analogs for diagnostic imaging |
| 04/13/2006 | US20060078494 Use of inhibitors of 24-hydroxylase in the treatment of cancer |
| 04/13/2006 | US20060078493 Methods and apparatus for localized administration of inhibitory moieties to a patient |
| 04/12/2006 | EP1644941A1 Magnetic nanoparticles having improved magnetic properties |
| 04/12/2006 | EP1644729A2 Anti-cd74 immunoconjugates and methods |
| 04/12/2006 | EP1644050A1 Bifunctional tridentate pyrazolyl containing ligands for re, tc and mn tricarbonyl complexes |
| 04/12/2006 | EP1644049A2 Method and device for radiotherapy |
| 04/12/2006 | EP1643958A2 Method for selective targeting of apoptotic cells and small molecule ligands used thereof |
| 04/12/2006 | EP1560602B1 Radioactive transition metal-imido hetero-diphosphine complexes, their preparation and radiopharmaceutical compositions thereof |
| 04/12/2006 | EP1270017B1 Radiolabeled pyrimidine nucleoside for the diagnosis of tissue-reproductive activity |
| 04/12/2006 | EP1005356B1 Novel antibacterial agents |
| 04/12/2006 | EP0843726B1 Opioid antagonists and methods of their use |
| 04/12/2006 | CN1758925A Methods of radiofluorination of biologically active vectors |
| 04/12/2006 | CN1250571C Specific binding molecules for scintigraphy, conjugates containing them and uses |
| 04/12/2006 | CN1250299C Implant with cavities containing therapeutic agents |
| 04/12/2006 | CN1250279C Liposome targeting of matrix metalloproteinase inhibitors |
| 04/11/2006 | US7026288 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin |
| 04/11/2006 | US7025991 Nanoparticle drug delivery |
| 04/11/2006 | US7025987 Delivery system for nucleic acids |
| 04/06/2006 | WO2006037124A2 Container with constrained quality maintenance agent |
| 04/06/2006 | WO2006037081A2 Nanoparticle radiosensitizers |
| 04/06/2006 | WO2006036892A2 Use of inhibitors of 24-hydroxylase in the treatment of cancer |
| 04/06/2006 | WO2006036777A2 Diagnosis of diseases associated with cox-2 expression |
| 04/06/2006 | WO2006036269A2 Microspheres capable of binding radioisotopes, optionally comprising metallic microparticles, and methods of use thereof |
| 04/06/2006 | WO2006036071A2 Urokinase plasminogen activator receptor targeted contrast agent |
| 04/06/2006 | US20060073150 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers |
| 04/06/2006 | US20060073140 Dual-specificity antibody having specificity for both an activated erbB2 receptor and erbB1 dimers, without significant affinity for monomeric EGFr that is not activate; specificity of the antibodies is due to their recognition and binding of activation epitopes; diagnosis, imaging and for treating tumor |
| 04/06/2006 | US20060073100 Detection and therapy of vulnerable plaque with fluorescent and/or radiolabeled compositions |
| 04/06/2006 | US20060073095 Methods for screening antibody-producing cells on heterogeneous antigen substrates |
| 04/06/2006 | CA2580464A1 Urokinase plasminogen activator receptor targeted contrast agent |
| 04/06/2006 | CA2579612A1 Microspheres capable of binding radioisotopes, optionally comprising metallic microparticles, and methods of use thereof |
| 04/05/2006 | EP1642968A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642967A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642909A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 04/05/2006 | EP1642907A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642906A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642596A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 04/05/2006 | EP1641806A2 Glycerophosphocholine and its derivatives for medical imaging of neuropsychiatric disorders |
| 04/05/2006 | EP1641495A2 Optically pure and enriched isomers of chelating ligands and contrast agents |
| 04/05/2006 | EP1641494A1 Tritiated growth hormone secretagogue mk-0677 |
| 04/05/2006 | EP1641493A1 Radiolabeled cannabinoid-1 receptor modulators |
| 04/05/2006 | EP1463533A4 Radioactive ion |
| 04/05/2006 | EP1320355B1 System for delivering a tobramycin formulation |
| 04/05/2006 | EP1049718B1 Use of the antibody 271.14d9.f8 (dsm acc2331) to inhibit in vitro alphavbeta6-integrin attachment to fibronectin |
| 04/05/2006 | CN1756561A Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins |
| 04/05/2006 | CN1249058C Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use |
| 04/04/2006 | US7022834 nucleotide synthesis; for measuring cellular proliferation and/or destruction rates by measuring DNA synthesis; mammalian cancer cells or cells infected with human immunodeficiency virus (HIV) |
| 04/04/2006 | US7022309 Targeting molecule linked to an imaging agent |
| 04/04/2006 | CA2233173C Dopamine and serotonin transporter ligands and imaging agents |
| 03/30/2006 | WO2006034207A2 Use of gsk3 inhibitors in combination with radiation therapies |
| 03/30/2006 | WO2006033714A2 Metal chelators and methods of their use |
| 03/30/2006 | WO2006032911A2 Metalloproteinase inhibitor imaging agents |
| 03/30/2006 | WO2006032704A2 Diagnostic compounds for targeting a chemokine receptor |
| 03/30/2006 | WO2006032127A1 Cytotoxicity mediation of cells evidencing surface expression of mcsp |
| 03/30/2006 | US20060067932 Antagonists specific for denatured collagen and methods of using same |
| 03/30/2006 | US20060067886 Competitive binding with bombesin; radiopharmaceuticals for treatment of neoplastic diseases |
| 03/30/2006 | US20060067885 ablating a targeted non-malignant B cell, comprising administering to a human subject having an immune disease an unconjugated monoclonal antibody (LL2 antibody) which binds to a marker that is specific for a B cell |
| 03/30/2006 | US20060067884 for radiolabeling proteins, peptides and ligands with therapeutic radioisotopes such that these radiolabeled agents may be administered directly to patients without the need for additional purification; for the treatment of cancer |
| 03/30/2006 | US20060067883 Microspheres capable of binding radioisotopes, optionally comprising metallic microparticles, and methods of use thereof |
| 03/30/2006 | US20060067882 Polymeric-matrix brachytherapy sources |
| 03/30/2006 | US20060067881 Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products |
| 03/30/2006 | US20060067880 Labeled creatine ethyl ester hydrochloride |
| 03/30/2006 | US20060067879 Diagnosis of diseases associated with COX-2 expression |
| 03/30/2006 | CA2579905A1 Cytotoxicity mediation of cells evidencing surface expression of mcsp |
| 03/30/2006 | CA2579801A1 Metalloproteinase inhibitor imaging agents |
| 03/29/2006 | EP1638613A1 Combination therapy of oxaliplatin and radioactively doped particles treating cancer |
| 03/29/2006 | EP1638612A2 Cox-2-targeted imaging agents |
| 03/29/2006 | EP1638510A2 Multivalent carriers of bi-specific antibodies |
| 03/29/2006 | EP1638460A1 Directing cells to target tissues or organs |
| 03/29/2006 | CN1754000A Methods for the prediction of suicidality during treatment |
| 03/29/2006 | CN1753878A Trimeric macrocyclic substituted benzene derivatives |
| 03/29/2006 | CN1751743A Method for preparing 131I marker GM-CSF protein for treating leukemia |
| 03/28/2006 | US7019109 SSTR1-selective analogs |
| 03/28/2006 | US7018614 Stabilization of radiopharmaceuticals labeled with 18-F |
| 03/28/2006 | US7018613 Preparations for evaluating eliminative ability of stomach |
| 03/28/2006 | US7018612 Method of preparing a radioactive rhenium complex solution |
| 03/28/2006 | US7018611 Vitronectin receptor antagonist pharmaceuticals |